Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo

Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways

(2019) Zuoxing Wu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo

(2018) Cheng-Ming Wei et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use

(2018) Yoshikazu Kinoshita et al.   Journal of Neurogastroenterology and Motility

Understanding the Bone in Cancer Metastasis

(2018) Jaime Fornetti et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteoblast autophagy in glucocorticoid-induced osteoporosis

(2018) Lufei Wang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades

(2017) Fangming Song et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Inhibition of titanium-particle-induced inflammatory osteolysis after local administration of dopamine and suppression of osteoclastogenesis via D2-like receptor signaling pathway

(2016) Huilin Yang et al.   BIOMATERIALS

Health worker perspectives on the possible use of intramuscular artesunate for the treatment of severe malaria at lower-level health facilities in settings with poor access to referral facilities in Nigeria: a qualitative study

(2016) Olatunde Adesoro et al.   BMC HEALTH SERVICES RESEARCH

Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases

(2016) Toru Hiraga   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate

(2016) Roman Thaler et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis

(2016) Xiang Zhu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Health worker and policy-maker perspectives on use of intramuscular artesunate for pre-referral and definitive treatment of severe malaria at health posts in Ethiopia

(2016) Takele Kefyalew et al.   MALARIA JOURNAL

Dihydroartemisinin attenuates lipopolysaccharide-induced osteoclastogenesis and bone loss via the mitochondria-dependent apoptosis pathway

(2016) C Dou et al.   Cell Death & Disease

Pantoprazole Decreases Cell Viability and Function of Human OsteoclastsIn Vitro

(2015) Markus Prause et al.   MEDIATORS OF INFLAMMATION

Proton pump (H+/K+-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats

(2014) Maria Pytlik et al.   Pharmacological Reports

Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity

(2013) João Costa-Rodrigues et al.   FEBS Journal

The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats

(2013) MOON KYUNG JOO et al.   Molecular Medicine Reports

Pantoprazole, a Proton Pump Inhibitor, Delays Fracture Healing in Mice

(2012) T. Histing et al.   CALCIFIED TISSUE INTERNATIONAL

V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption

(2012) De-Qin Yang et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: A prospective matched controlled study

(2012) Ala I. Sharara et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Intercellular Cross-Talk Among Bone Cells: New Factors and Pathways

(2012) Natalie A. Sims et al.   Current Osteoporosis Reports

Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies

(2011) Saowanee Ngamruengphong et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Proton pump inhibitors therapy and risk of hip fracture

(2011) Xiaofei Ye et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Versatile Roles of V-ATPases Accessory Subunit Ac45 in Osteoclast Formation and Function

(2011) An Qin et al.   PLoS One

Effect of omeprazole on the expression of transcription factors in osteoclasts and osteoblasts

(2010) Chun   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Use of Gastrointestinal Proton Pump Inhibitors to Regulate Osteoclast- Mediated Resorption of Calcium Phosphate Cements In Vivo

(2009) A. Sheraly et al.   Current Drug Delivery

Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults

(2008) Elaine W. Yu et al.   CALCIFIED TISSUE INTERNATIONAL

Use of proton pump inhibitors and risk of osteoporosis-related fractures

(2008) L. E. Targownik et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL